Hyun D. Kim
Corporate Officer/Principal presso EMBER THERAPEUTICS, INC.
Posizioni attive di Hyun D. Kim
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Hyun D. Kim
Precedenti posizioni note di Hyun D. Kim
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Olympus Biotech Corp. (United States) | Direttore Tecnico/Scientifico/R&S | - | - |
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Direttore Tecnico/Scientifico/R&S | - | - |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formazione di Hyun D. Kim
| Brown University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EMBER THERAPEUTICS, INC. | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
Transport Pharmaceuticals, Inc.
Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
| Olympus Biotech Corp. (United States) |
- Borsa valori
- Insiders
- Hyun D. Kim
- Esperienza
